TELA Bio, Inc. (TELA) Misses Q4 EPS by 11c

TELA Bio, Inc. (NASDAQ: TELA) reported Q4 EPS of ($0.53), $0.11 worse than the analyst estimate of ($0.42). Revenue for the quarter came in at $17 million versus the consensus estimate of $16.39 million.

For earnings history and earnings-related data on TELA Bio, Inc. (TELA) click here.

You May Also Be Interested In

• Mizuho says ignore Apple noise, flags key catalyst for Micron and memory in H2
• Jefferies Downgrades United Spirits Ltd. (UNITDSPR:IN) to Hold
• Hormel Foods agrees to sell Brazil's Ceratti brand to Zanchetta